Clinical Trial Update: Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders [Phase 3]

View source ↗

Summary

A Phase 3 study investigating amitriptyline for repetitive behaviors in autism spectrum disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• amitriptyline (amitriptyline)

Snippet

Sponsor: University of Missouri, Kansas City | Conditions: Autism Spectrum Disorder, Repetitive Compulsive Behavior | Phase 3 | Status: TERMINATED